Edition:
United Kingdom

Erytech Pharma ‍announces pricing of global offering of 5.4 mln new ordinary shares​


Friday, 10 Nov 2017 

Nov 10 (Reuters) - ERYTECH PHARMA SA ::‍ANNOUNCES PRICING OF GLOBAL OFFERING TO SPECIFIED CATEGORIES OF INVESTORS OF AGGREGATE OF 5.4 MILLION NEW ORDINARY SHARES​.‍GLOBAL OFFERING COMPRISING AN OFFER OF 4.7 MILLION ORDINARY SHARES IN FORM OF AMERICAN DEPOSITARY SHARES​.IN ‍UNITED STATES, OFFERING PRICE OF $23.26 PER ADS​.‍PRIVATE PLACEMENT IN EUROPE (INCL. FRANCE) AND OTHER COUNTRIES (EXCLUDING. US AND CANADA) OF 0.7 MILLION ORDINARY SHARES AT OFFERING PRICE OF EUR 20 PER SHARE.‍LISTING ON NASDAQ GLOBAL SELECT MARKET UNDER TICKER SYMBOL "ERYP"​.‍GLOBAL OFFERING FOR TOTAL GROSS PROCEEDS OF ABOUT $125 MILLION BEFORE DEDUCTING UNDERWRITING COMMISSIONS AND ESTIMATED EXPENSES PAYABLE BY CO​.‍CLOSING OF GLOBAL OFFERING EXPECTED ON OR ABOUT NOV 14, 2017​.‍FOLLOWING CLOSING COMPANY WILL HAVE ISSUED 5,374,033 ORDINARY SHARES (INCL. ADSS)​.